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ABSTRACT 
Summary: The genomics era provides opportunities to assess the 
genetic overlap across phenotypes at the measured genotype level; 
however current approaches require individual-level genome-wide 
association (GWA) single nucleotide polymorphism (SNP) genotype 
data in one or both of a pair of GWA samples. To facilitate the dis-
covery of pleiotropic effects and examine genetic overlap across two 
phenotypes I have developed a user-friendly web-based application 
called SECA to perform SNP effect concordance analysis using 
GWA summary results. The method is validated using publicly avail-
able summary data from the Psychiatric Genomics Consortium. 
Availability: http://neurogenetics.qimrberghofer.edu.au/SECA 
Contact: dale.nyholt@qimrberghofer.edu.au 
Supplementary information: Supplementary data are available at 
Bioinformatics online. 
1 INTRODUCTION  
Epidemiological and clinical studies indicate many human com-
plex disorders co-occur within an individual, while family and twin 
studies suggest correlations in familial and genetic liabilities. Since 
2007, over 1700 GWA studies (GWAS) have been performed to 
identify common SNPs, associated with over 890 phenotypes (dis-
ease endpoints or quantitative traits) (Hindorff, et al., 2011) 
(www.genome.gov/gwastudies, accessed September 18, 2013). A 
surprising finding of GWAS is that many loci show pleiotropic 
effects by being associated with more than one distinct phenotype. 
Indeed, a study of 1380 genes and 1687 SNPs listed in the NHGRI 
Catalog of Published GWAS (www.genome.gov/gwastudies, ac-
cessed February 4, 2011) found 16.9% of genes and 4.6% of SNPs 
show pleiotropic effects (Sivakumaran, et al., 2011). 
Identifying and taking advantage of genetic overlap across phe-
notypes can improve detection of genetic risk factors, because 
when risk is correlated across phenotypes, pooled analyses will be 
better powered than individual-disorder analyses. Genetic overlap 
can also help determine whether our current classification and 
categorization of diseases are valid or whether genetic similarities 
traverse current divisions. Understanding pleiotropic effects is also 
important for drug development. For example, if a gene has oppos-
ing effects on different common diseases, drug development and 
marketing will be greatly complicated. Knowledge of pleiotropic 
associations could help to predict and avoid adverse side effects. 
Polygenic prediction, or genetic risk score (GRS), analysis 
(Purcell, et al., 2009) and bivariate linear mixed model (bivariate-
GCTA) analysis (Lee, et al., 2012) have recently been developed 
to assess the genetic overlap across phenotypes. 
GRS analysis requires GWAS summary results for a discovery 
sample (dataset1) to construct a score in an independent target 
sample (dataset2) by forming the weighted sum of associated al-
leles (i.e., a GRS) within each subject (thus requiring individual-
level GWA SNP genotype data for the target sample). Association 
between the GRS and a phenotype in the target sample implies 
genetic overlap between the discovery and target phenotypes. 
The bivariate-GCTA approach requires individual-level popula-
tion-based GWA SNP genotype data for both the discovery and 
target sample to estimate the genetic correlation explained by 
SNPs between pairs of quantitative traits or pairs of binary traits. 
For example, the SNP-based genetic correlation (rg SNP) will be 
positive when the cases of one (discovery) trait show higher genet-
ic similarity (i.e., pairwise genetic relationship estimated from 
genome-wide SNP genotype data) to the cases of the other (target) 
trait, than they do to their own (discovery) controls. 
The sharing of individual-level genotype and phenotype data re-
quires application, material transfer agreement, informed consent 
and ethical consideration (McGuire, et al., 2011). Given most large 
GWA studies meta-analyze summary results from multiple inde-
pendent samples, the sharing of individual-level GWA SNP geno-
type data is often very difficult, if not impossible. Therefore, to 
overcome these challenges I have developed a user-friendly web-
based application called SECA to perform SNP effect concordance 
analysis using GWAS summary results. 
2 METHODS 
SECA analyses two sets of GWAS summary results (Supplementary Figure 
1), each containing five essential columns: i) reference SNP cluster 'rs' ID 
(SNP), ii) effect allele (EA), iii) non-effect allele (NEA), iv) p-value from 
association test (P), and v) regression coefficient (BETA), odds ratio (OR), 
or signed z-score (ZSCORE) for the EA relative to the NEA. 
SECA first aligns the SNP effects across the two GWAS summary re-
sults (dataset1 and dataset2) to the same EA, and extracts a subset of inde-
pendent SNPs via linkage disequilibrium (LD) clumping using the PLINK 
program (Purcell, et al., 2007). The default clumping procedure is 'p-value 
informed'. The approach iterates from the first to last SNP on each chromo-
some sorted from smallest to largest p-value in dataset1 (P1) that has not 
already been clumped (denoting this as the index SNP) and forms clumps 
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of all other SNPs that are within 1 Mb and in LD (r2 > 0.1) with the index 
SNP based on HapMap or 1000 Genomes Project (1kGP) genotype data. A 
second round of LD clumping is performed to ensure none of the round 1 
index SNPs within 10 Mb of each other are in long-range LD (r2 > 0.1). 
The default approach identifies the subset of independent SNPs with the 
most significant association p-values in dataset1. An alternate LD clump-
ing approach identifies an effectively random subset of independent SNPs 
by setting all dataset1 p-values (P1) to 0.5 during the clumping rounds.  
Restricting to SNPs associated with P1 ≤ {0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 
0.5, 0.6, 0.7, 0.8, 0.9, 1.0} in dataset1, SECA first performs exact binomial 
statistical tests using the R statistical package (R Development Core Team, 
2009) to determine whether there is an excess of SNPs associated in both 
datasets for the subset of SNPs associated with P2 ≤ {0.01, 0.05, 0.1, 0.2, 
0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0} in dataset2. For each of the 144 SNP 
subsets (generated using these 12 × 12 p-value threshold combinations), 
binomial tests of associated SNPs in dataset1 (P1) and dataset2 (P2) are 
performed. A binomial test 'heatmap' plot is generated to graphically sum-
marize the proportion of SNP subsets with an excess [observed (obs) ≥ 
expected (exp)] or deficit (obs < exp) number of associated SNPs, and 
empirical p-values (adjusted for testing all 144 subsets) are calculated via 
permutation. The permutation procedure first creates uncorrelated datasets 
by randomly shuffling the observed SNP effect (BETA) and corresponding 
p-value (P) between SNPs in dataset1, and then repeats the analysis of the 
144 SNP subsets. A permuted p-value (PBTsig-permuted) is estimated for the 
observed number of binomial tests with obs ≥ exp and PBT ≤ 0.05 (nBTsig), 
and for the single most significant excess (PBTmin-permuted). We note that for 
polygenic traits, a well-powered GWAS should produce an excess of 
smaller p-values (Yang, et al., 2011). Therefore, instead of specifying P2 as 
the expected proportion of SNPs with P1 and P2, the proportion of SNPs 
associated in dataset2 (irrespective of its p-value in dataset1) is utilized as 
the 'overlap' (null) probability (i.e., 'expected proportion') in the binomial 
tests. For example, the observed proportion of total SNPs with P1 ≤ 1 and 
P2 ≤ 0.05 is used as the expected proportion of SNPs with P1 ≤ {0.01, 0.05, 
0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0} and P2 ≤ 0.05.  
SECA next performs Fisher's exact statistical tests to determine whether 
there is an excess of SNPs where the effect directions (BETA, OR, or 
ZSCORE) are concordant across dataset1 and dataset2 for each of the 144 
SNP subsets. Fisher's exact  tests of SNP effects in dataset1 (e.g., OR1) and 
dataset2 (OR2) are performed on 2 × 2 tables containing the number of 
SNPs with OR1 < 1 (BETA1/ZSCORE1 < 0) and OR2 < 1, OR1 ≥ 1 
(BETA1/ZSCORE1 ≥ 0) and OR2 < 1, OR1 < 1 and OR2 ≥ 1, and OR1 ≥ 1 
and OR2 ≥ 1. A Fisher's test 'heatmap' plot is generated to graphically 
summarize the proportion of SNP subsets with concordant (Fisher's test 
odds ratio, ORFT ≥ 1) and discordant (ORFT < 1) SNP effects and an empiri-
cal p-value (PFTsig-permuted) is calculated via permutation for the observed 
number of subsets (nFTsig) with nominally significant concordance (ORFT ≥ 
1 and PFT ≤ 0.05). A permuted p-value is also estimated for the single most 
significant concordant test (PFTmin-permuted).  
In addition to a summary of the above analyses, SECA reports detailed 
results from binomial and Fisher's tests for three practical subsets of SNPs 
which are nominally associated (P2 ≤ 0.05) in dataset2 and i) genome-wide 
significant (P1 ≤ 5 × 10-8), ii) genome-wide suggestive (P1 ≤ 1 × 10-5), and 
iii) nominally associated (P1 ≤ 0.05) in dataset1. 
A 'grid' search is also performed across 150 p-value thresholds to identi-
fy the subset of SNPs overlapping dataset1 and dataset2 that produce the 
minimum binomial test ('pleiotropic') p-value and minimum Fisher's test 
(effect concordance) p-value. The search is performed at 5 equidistant p-
value {P1, P2} increments for the interval [5 × 10-8, 9 × 10-8], i.e., {5 × 10-8, 
6 × 10-8, 7 × 10-8, 8 × 10-8, 9 × 10-8}; 9 equidistant increments for each of 
the intervals [1 × 10-7, 9 × 10-7], [1 × 10-6, 9 × 10-6], [1 × 10-5, 9 × 10-5], [1 × 
10-4, 9 × 10-4], [1 × 10-3, 9 × 10-3]; and 100 increments of 0.01 between 0.01 
and 1.0. The results from all 150 × 150 = 22500 SNP subsets are output to 
enable post-hoc examination of SNP overlap and concordance across the 
full range of statistical significance in dataset1 and dataset2. 
Additionally, SECA generates quantile-quantile (Q-Q) and true discov-
ery rate (TDR) plots for dataset2 p-values (P2) stratified (conditioned) on 
dataset1 p-values (P1 ≤ {0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1.0}) to visualize 
whether there is an excess of overlapping ('pleiotropic') SNPs. A leftward 
shift in the Q-Q or TDR curve corresponds to an excess of SNPs with 
smaller p-values. In the presence of pleiotropy, we expect the Q-Q and 
TDR curves for dataset2 SNP p-values (P2) to deviate further left of the 
identity line as we condition on them having smaller p-values (P1) in da-
taset1. Finally, 'pleiotropy-informed' conditional false discover rate (FDR) 
results are output for dataset2 p-values (P2) stratified on dataset1 p-values 
(P1 ≤ {1.0, 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, 0.1, 0.05, 0.01, 0.001, 
0.0001, 0.00001}). These results may identify SNPs associated in dataset2 
after conditioning on their association significance (P1) in dataset1 and 
help prioritize SNPs for follow-up studies. Coincidently, Andreassen and 
colleagues (Andreassen, et al., 2013) developed in parallel (but without 
accompanying software), similar Q-Q and TDR plot and FDR-based ap-
proaches to identify pleiotropic effects. An overview of the SECA ap-
proach is provided in Supplementary Figure 2. 
Resources to customize LD clumping, an alternate version of SECA 
(iSECA) which assumes the SNPs in dataset1 to be independent, and an R 
script allowing users to alter the number of replicates (default = 1000) for 
the permutation of binomial and Fisher's test p-values are also provided. 
3 RESULTS 
Using publicly available GWAS summary data, SECA corrobo-
rates recent results from the Cross-Disorder Group of the Psychiat-
ric Genomics Consortium (Smoller, et al., 2013), finding signifi-
cant polygenic overlap between bipolar disorder, major depressive 
disorder, schizophrenia and autism spectrum disorder, but general-
ly not with attention deficit-hyperactivity disorder (further details 
and results are provided in the Supplementary material). 
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